JPWO2020165181A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020165181A5 JPWO2020165181A5 JP2021547154A JP2021547154A JPWO2020165181A5 JP WO2020165181 A5 JPWO2020165181 A5 JP WO2020165181A5 JP 2021547154 A JP2021547154 A JP 2021547154A JP 2021547154 A JP2021547154 A JP 2021547154A JP WO2020165181 A5 JPWO2020165181 A5 JP WO2020165181A5
- Authority
- JP
- Japan
- Prior art keywords
- erdafitinib
- cancer
- specifically
- daily
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19156806 | 2019-02-12 | ||
| EP19156806.2 | 2019-02-12 | ||
| EP19176575 | 2019-05-24 | ||
| EP19176575.9 | 2019-05-24 | ||
| PCT/EP2020/053490 WO2020165181A1 (en) | 2019-02-12 | 2020-02-11 | Cancer treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521173A JP2022521173A (ja) | 2022-04-06 |
| JPWO2020165181A5 true JPWO2020165181A5 (enExample) | 2023-02-21 |
Family
ID=69467563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547154A Withdrawn JP2022521173A (ja) | 2019-02-12 | 2020-02-11 | 癌治療 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20220168298A1 (enExample) |
| EP (1) | EP3923942A1 (enExample) |
| JP (1) | JP2022521173A (enExample) |
| KR (1) | KR20210126654A (enExample) |
| CN (1) | CN113423402A (enExample) |
| AU (1) | AU2020223467B2 (enExample) |
| BR (1) | BR112021015686A2 (enExample) |
| CA (1) | CA3126959A1 (enExample) |
| IL (1) | IL285466A (enExample) |
| JO (1) | JOP20210216A1 (enExample) |
| MA (1) | MA54932A (enExample) |
| MX (1) | MX2021009670A (enExample) |
| PH (1) | PH12021551949A1 (enExample) |
| SG (1) | SG11202107850VA (enExample) |
| TW (1) | TWI863962B (enExample) |
| WO (1) | WO2020165181A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117083283A (zh) * | 2020-12-11 | 2023-11-17 | 医睿世康药业研发公司 | 用于癌症治疗的联合疗法 |
| WO2022125967A2 (en) * | 2020-12-11 | 2022-06-16 | Erasca, Inc. | Combination therapies for the treatment of cancer |
| CN112957368A (zh) * | 2021-04-02 | 2021-06-15 | 南昌大学 | 一种司维拉姆的新用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX392774B (es) * | 2014-09-26 | 2025-03-24 | Janssen Pharmaceutica Nv | Uso de paneles de genes mutantes de fgfr en la identificacion de pacientes con cancer que responderán al tratamiento con un inhibidor fgfr |
| JOP20200201A1 (ar) * | 2015-02-10 | 2017-06-16 | Astex Therapeutics Ltd | تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين |
| US10208024B2 (en) * | 2015-10-23 | 2019-02-19 | Array Biopharma Inc. | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases |
| JOP20190190A1 (ar) * | 2017-02-06 | 2019-08-04 | Janssen Pharmaceutica Nv | معالجة سرطان |
| JOP20190280A1 (ar) * | 2017-06-02 | 2019-12-02 | Janssen Pharmaceutica Nv | مثبطات fgfr2 لعلاج سرطان الأوعية الصفراوية |
| EA201991818A1 (ru) * | 2017-12-20 | 2020-02-05 | Янссен Фармацевтика Нв | Лечение рака |
-
2020
- 2020-02-11 AU AU2020223467A patent/AU2020223467B2/en active Active
- 2020-02-11 WO PCT/EP2020/053490 patent/WO2020165181A1/en not_active Ceased
- 2020-02-11 KR KR1020217028671A patent/KR20210126654A/ko active Pending
- 2020-02-11 US US17/430,025 patent/US20220168298A1/en active Pending
- 2020-02-11 PH PH1/2021/551949A patent/PH12021551949A1/en unknown
- 2020-02-11 CA CA3126959A patent/CA3126959A1/en active Pending
- 2020-02-11 SG SG11202107850VA patent/SG11202107850VA/en unknown
- 2020-02-11 BR BR112021015686-0A patent/BR112021015686A2/pt unknown
- 2020-02-11 MA MA054932A patent/MA54932A/fr unknown
- 2020-02-11 EP EP20703477.8A patent/EP3923942A1/en active Pending
- 2020-02-11 MX MX2021009670A patent/MX2021009670A/es unknown
- 2020-02-11 CN CN202080013784.5A patent/CN113423402A/zh active Pending
- 2020-02-11 JP JP2021547154A patent/JP2022521173A/ja not_active Withdrawn
- 2020-02-11 JO JOP/2021/0216A patent/JOP20210216A1/ar unknown
- 2020-02-12 TW TW109104389A patent/TWI863962B/zh active
-
2021
- 2021-08-09 IL IL285466A patent/IL285466A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4337191B1 (en) | Egfr inhibitor for the treatment of head and neck cancer | |
| CN104884055A (zh) | 柠檬酸铁在治疗慢性肾脏疾病患者中的应用 | |
| JP2020505425A5 (enExample) | ||
| JP2014513705A (ja) | 進行性固形腫瘍の治療方法 | |
| TW201906633A (zh) | 用於增進癌症化學療效之組合物及方法 | |
| WO2023170065A1 (en) | Methods of treating small cell lung cancer | |
| TW201907916A (zh) | 基於癌細胞之代謝特異性之新穎抗惡性腫瘤劑 | |
| JP2021063014A (ja) | 白血病治療薬 | |
| JPWO2020165181A5 (enExample) | ||
| TW202304424A (zh) | 包含依維莫司和安森司群的組合 | |
| US20230038138A1 (en) | Combination therapy for treating cancer | |
| CN120022281A (zh) | Cdk4/6抑制剂的联用药物组合物及其用途 | |
| JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および／または症状軽減剤 | |
| WO2021160147A1 (zh) | 吡啶并[1,2-a]嘧啶酮化合物的治疗淋巴瘤的用途 | |
| US20190183893A1 (en) | Low dose of sildenafil as an antitumor drug | |
| TW201521742A (zh) | 具降低毒性之庫司替森（ｃｕｓｔｉｒｓｅｎ）療法 | |
| EP4110326B1 (en) | Combination comprising alpelisib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid | |
| CN108836965A (zh) | 尼克酰胺组合物在制备治疗索拉非尼手足皮肤反应药物中的应用 | |
| CN109106720B (zh) | 西达本胺与依西美坦在制备用于治疗乳腺癌的联合用药物中的用途及联合用药物 | |
| CN107661324B (zh) | 普罗帕酮在制备治疗食管癌药物中的应用 | |
| EP4452275B1 (en) | Combination of cisplatin and elimusertib for the treatment of pediatric liver cancers | |
| RU2852638C2 (ru) | Противораковый состав, содержащий пентаборат натрия, куркумин и пиперин, для применения для лечения печеночно-клеточной карциномы | |
| JP7450037B2 (ja) | 脳転移を有する末期非小細胞肺がん患者を治療するための組み合わせ医薬品 | |
| WO2018201920A1 (zh) | 龙虎人丹在制备预防和/或治疗肝纤维化药物中的应用 | |
| CN109771437B (zh) | 三氟胸苷在制备治疗三阴性乳腺癌药物中的应用 |